Betül Emine DERİNKUYU, Melek Melehat OĞUZ, Ebru AZAPAĞASI, Ülkühan ÖZTOPRAK, Erhan AKSOY, Halil ÇELİK, Deniz YÜKSEL, Nesrin CEYLAN, Suna ÖZDEM

Clinically mild encephalitis/encephalopathy with a reversible splenial lesion of the corpus callosum in childhood: a single-center experience

Background/aim: Mild encephalitis/encephalopathy with a reversible splenial lesion (MERS) is a rare clinicoradiological syndrome that typically presents with central nervous system symptoms such as loss of consciousness, seizure, headache, and ophthalmoparesis. Materials and methods: Here, we highlight the characteristics of this syndrome together with the clinical and MRI findings of 6 pediatric patients with MERS. Results: Between January 2017 and October 2020, 6 patients with MERS (3 boys and 3 girls) presented to our center. The mean age was 122 ± 54.6 (min-max: 44-180) months. None of the patients had a chronic disease. In our study, infectious agents were detected in 4 patients (66.6%), while noninfectious causes (one seizure and the other hyponatremia) were detected in two patients. All of our cases were discharged without any sequelae after an average of 12.1 ± 7 (min–max: 4–20) days of hospitalization. In 1 patient (case 6), control MRI could not be performed, and the radiological recovery of our other patients was shown to be between 14 days and 2 months. Conclusion: MERS is an acute encephalopathy with good prognosis and should be considered by neurologists in differential diagnosis due to its variable clinical presentation and specific MRI findings.

PDF

___

1. Ueda N, Minami S, Akimoto M. Mycoplasma pneumoniaeassociated mild encephalitis/encephalopathy with a reversible splenial lesion: report of two pediatric cases and a comprehensive literatüre review. BMC Infectious Diseases 2016; 16:671. Doi:10.1186/s12879-016-1985-1
2. Fang Q, Chen L, Chen Q, Lin Z, Yang F. Clinically mild encephalitis/ encephalopathy with a reversible splenial lesion of corpus callosum in Chinese children. Brain and Development 2017; 39:321–326. Doi:10.1016/j.braindev.2016.10.009
3. Karampatsas K, Spyridou C, Morrison IR, Tong CY, Prendergast AJ. Rotavirus-associated mild encephalopathy with a reversible splenial lesion (MERS)-case report and review of the literature. BMC Infectious Diseases 2015; 15:446. Doi:10.1186/s12879- 015-1192-5
4. Fong CY, Khine MM, Peter AB, Lim WK, Rozalli FI et al. Mild encephalitis/encephalopathy with reversible splenial lesion (MERS) due to dengue virus. Journal of Clinical Neuroscience 2017; 36:73–75.doi:10.1016/j.jocn.2016.10.050
5. Avcu G, Kilinc MA, Eraslan C, Karapinar B, Vardar F. Mild encephalitis/encephalopathy with reversible splenial lesion (MERS) associated with Streptococcus pneumoniae Bacteraemia. Journal of Infection and Public Health 2017; 10:479–482. Doi:10.1016/j.jiph.2016.08.019
6. Cortese R, Pontrelli G, Mogavero MP, Dicuonzo F, Tortorella C. Reversible splenial lesion and complex visual disturbances due to carbamazepine with drawal. Neurological Science 2015; 36: 1515–1516. Doi:10.1007/s10072-015-2144-y
7. Takanashi J, Imamura A, Hayakawa F, Terada H. Differences in the time course of splenial and White matter lesions in clinically mild encephalitis/encephalopathy with a reversible splenial lesion (MERS). Journal of Clinical Neuroscience 2010;292:24 –27. Doi:10.1016/j.jns.2010.02.013
8. Tada H, Takanashi J, Barkovich A, Oba H, Maeda M et al. Clinically mild encephalitis/ encephalopathy with a reversible splenial lesion. Neurology. 2004;63:1854–8. Doi:10.1212/01. wnl.0000144274.12174.cb
9. Galllucci M, Limbucci N, Paonessa A, Caranci F. Reversible focal splenial lesions. Neuroradiology 2007; 49: 541-4.doi:10.1007/ s00234-007-0235-z
10. Renard D, Bonafe A, Heroum C. Transient lesion in the splenium of the corpus callosum after oral corticoid therapy. European Journal of Neurology 2007;14:19-20. Doi:10.1111/j.1468- 1331.2007.01872.x
11. Marsala SZ, Antichi E, Pistacchi M, Gioulis M, Candeago RM et al. Mild encephalitis with a reversible splenial lesion: A clinical benign condition, often underrecognized-Clinical case and literatüre review. Journal of neurosciences in rural practice 2017;8(2):281. Doi:10.4103/0976-3147.203828
12. Wilson CA, Mullen MT, Jackson BP, Ishida K, Messé SR. Etiology of corpus callosum lesions with restricted diffusion. Clinical neuroradiology 2017;27(1):31–7. Doi:10.1007/s00062-015- 0409-8
13. Kashiwagi M, Tanabe T, Shimakawa S, Nakamura M, Murata S et al. Clinico-radiological spectrum of reversible splenial lesions in children. Brain and Development, 2014;36(4): 330-336. doi:10.1016/j.braindev.2013.05.007
14. Ka A, Britton P, Troedson C, Webster R, Procopis P et al. Mild encephalopathy with reversible splenial lesion: an important differential of encephalitis. European Journal of Paediatric Neurology 2015; 19:377–82. Doi:10.1016/j.ejpn.2015.01.011
15. Chen WX, Liu HS, Yang SD, Zeng SH, Gao YY et al. Reversible splenial lesion syndrome in children: Retrospective study and summary of case series. Brain and Development 2016;38:915– 27. Doi:10.1016/j.braindev.2016.04.011
16. Takanashi J, Miyamoto T, Ando N, Kubota T, Oka M et al. Clinical and radiological features of rotavirus cerebellitis. American Journal of Neuroradiology. 2010;31:1591-1595. Doi:10.3174/ ajnr.a2131
17. Yamaguchi H, Ishida T, Yokoi T, Tanaka T, Maruyama A et al. Clinically Mild Encephalitis/Encephalopathy. Journal of Pediatric Hematology and Oncology. 2017; 39:e 92-6. Doi:10.1097/mph.0000000000000708
18. Guo Y, Wang S, Jiang B, Li J, Liu L. et al. Encephalitis with reversible splenial and deep cerebral White matter lesions associated with Epstein-Barr virüs infection in adults. Neuropsychiatric Disease and Treatment 2017;13:2085–92. Doi:10.2147/ndt.s135510
19. Abdel-Mannan O, Eyre M, Lobel U, Bamford A, Eltze C et al. Neurologic and radiographic findings associated With COVID-19 infection in children. JAMA Neurology 2020 ;77(11):1440-1445. Doi:10.1001/jamaneurol.2020.2687
20. Bektas G, Akcay N, Boydag K, Sevketoglu E. Reversible splenial lesion syndrome associated with SARS-CoV-2 infection in two children . Brain and Development. 2021;43:230-3. doi:10.1016/j.braindev.2020.10.002
21. Takanashi J, Tada H, Maeda M, Suzuki M, Terada H et al. Encephalopathy with a reversible splenial lesion is associated with hyponatremia. Brain and Development 2009; 31:217–220 doi:10.1016/j.braindev.2008.04.002
22. Xinying Zhang, Na Chen, Jiamin Guo, Shuwei Li, Jiaming Xu et al. Reversible splenial lesion syndrome in children: clinical analysis and summary of a case series. Journal of International Medical Research. 2020;48(4):300060520914202. Doi:10.1177/0300060520914202